Lapatinib Ditosylate Tablets

GlaxoSmithKline AG🇨🇳 National Medical Products Administration

Approval Id: 8BYsaQLiSi2
Approval Number: 国药准字HJ20171252
Generic Name: 甲苯磺酸拉帕替尼片
Generic Name En: Lapatinib Ditosylate Tablets
Trade Name: 泰立沙
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 0.25g
Reg Date: 2021-08-09
Expired Date: 2026-08-08
Company Name: GlaxoSmithKline AG
Company Address: Talstrasse 3-5, 3053 Münchenbuchsee, Switzerland
Production Company Name: glaxo operations uk limited,(trading as glaxo wellcome operations)
Production Company Address: Priory Street, Ware, Hertfordshire SG12 0DJ
Company Detail Path: /organization/glaxosmithkline-ag

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 9, 2021

Approval ID

8BYsaQLiSi2

Type

化学药品